Chemotherapy

 

Action

 

Chemotherapy indiscriminately kills rapidly dividing cells.

Malignant cells have limited ability to repair themselves when injured.

Normal cells are more successful at repair

  • Bone marrow
  • Epidermal cells
  • Epithelial cells lining the Gastrointestinal tract (GI), oropharynx
  • Hair follicles

Antineoplastic agents are designed to kill rapidly dividing cells

Based on concepts of:

  • Cellular kinetics and cell life cycle
  • Cell cycle time
  • Growth fraction
  • Tumor burden

 

CELL LIFE CYCLE

Gap 0 (G0) = Resting phase. Cells not dividing. Some cells spend little or no time in G0 (eg. epithelial cells, malignant cells)

Gap 1 (G1) = Post mitotic phase. Enzymes necessary for DNA synthesis produced. Protein and RNA synthesis occurs. Time span highly variable, which accounts for the differences in cell-doubling times for different types of cells.

Synthesis (S) = Cellular DNA duplicated

Gap 2 (G2) = Premitotic phase. Precursors of mitotic spindle produced.

Mitosis (M) = Cell division in 4 step process

  • Prophase
  • Metaphase
  • Anaphase
  • Telophase

 

CELL CYCLE TIME

  • Amount of time required for cell to move from one mitosis to another.
  • Length of total cell cycle varies with specific type of cell
  • Length of time spent in G0 varies
  • Shorter cell cycle time results in higher cell kill

 

CELL KILL HYPOTHESIS

  • Small percentage of cells killed with each chemotherapy cycle
  • Ultimately only a few cells remain which the immune system destroys
  • Rationale for multiple cycles of chemotherapy

 

TUMOR GROWTH FRACTION/ TUMOR BURDEN

Growth fraction = Percentage of cells actively dividing at a given point in time

  • Higher growth fraction results in a higher cell kill with cell cycle specific agents
  • Higher number in G0 will be more sensitive to cell cycle non-specific agents

Tumor burden = Number of cells present in a tumor

  • Cancers with small tumor burden more responsive to therapy
  • A high tumor cell burden leads to drug resistance

 

Back to top

Next